Sponsor
  • ·
  • Chinese Association of
    Integrative Medicine;
    China Academy of Chinese
    Medicine Sciences
Editing
  • ·
  • Editorial Board of
    China Journal of
    Orthopaedics and Traumatology
Publishing
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
Overseas Distributor
  • ·
  • China International Book
    Trading Corporation
    P.O.Box 399,Beijing,China
    Code No.M587
Mail-order
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
    No.16A, Nanxiaojie, Dongzhimennei,
    Beijing 100700,China
    Tel:0086-10-84020925
    Fax:0086-10-84036581
    Http://www.zggszz.com
    E-mail:zggszz@sina.com
耐药脊柱结核的外科治疗
Hits: 2509   Download times: 1543   Received:May 24, 2010    
作者Author单位UnitE-Mail
李大伟 LI Da-wei 中国人民解放军第309医院骨科,北京 100091 Department of Orthopaedics,the 309th Hospital of PLA,Beijing 100091,China myzzxq@sina.com 
马远征 MA Yuan-zheng 中国人民解放军第309医院骨科,北京 100091 Department of Orthopaedics,the 309th Hospital of PLA,Beijing 100091,China  
侯英 HOU Ying 解放军结核病中心研究室 Department of Orthopaedics,the 309th Hospital of PLA,Beijing 100091,China  
薛海滨 XUE Hai-bin 中国人民解放军第309医院骨科,北京 100091 Department of Orthopaedics,the 309th Hospital of PLA,Beijing 100091,China  
黄凤山 HUANG Feng-shan 中国人民解放军第309医院骨科,北京 100091 Department of Orthopaedics,the 309th Hospital of PLA,Beijing 100091,China  
期刊信息:《中国骨伤》2010年23卷,第7期,第485-487页
DOI:10.3969/j.issn.1003-0034.2010.07.003


目的:探讨耐药脊柱结核的外科治疗及疗效。

方法:对2005年3月至2009年4月收治的60例耐药脊柱结核的临床资料进行回顾性分析,男36例,女24例,年龄5~79岁,平均47.3岁。其中34例患者有神经受损症状,神经功能按ASIA分级标准:A级2例,B级5例,C级13例,D级14例。根据病灶部位及病变程度采用经脊柱前路、肋横突或后路病灶清除、植骨、内固定。并在药敏试验结合耐药基因检测指导下抗结核治疗12~18个月。观察患者复发、神经功能恢复、植骨融合情况。

结果:所有患者均获得随访,时间1~5年,平均3.1年。2例术后复发,经再次手术治愈。神经功能受损的34例,术后改善或完全恢复。X线或CT检查提示57例患者植骨融合。

结论:对耐药脊柱结核,药敏试验结合耐药基因检测指导下抗结核治疗,个体化术式选择,有较好的临床疗效。
[关键词]:结核,脊柱  外科手术  结核,抗多种药物性
 
Surgical treatment of drug-resistant spinal tuberculosis
Abstract:

Objective: To study the curative effect of surgical treatment of drug-resistant spinal tuberculosis.

Methods: From March 2005 and April 2009,the clinical data of 60 patients with drug-resistant spinal tuberculosis were retrospectively analyzed. Including 36 males and 24 females;aged from 5 to 79 years with an average of 47.3 years. Thirty-four patients had neurological deficits,among them,2 cases were grade A,5 cases were grade B,13 cases were grade C,14 cases were grade D according to ASIA standard. According to the severity and location of the infection,the patients underwent anterior,posterolateral costotransversectomy or posterior debridement and bone grafting and internal fixation.The antituberculous chemotherapy for a total of 12 to 18 months was guided by conventional and genotypic drug susceptibility testing. Tubercular relapse,neurological function,spinal fusion were observed by ASIA grade,X-ray and CT scan.

Results: All cases were followed up from 1 to 5 years with an average of 3.1 years. Recurrence was found in 2 cases who were cured after second operation. 34 cases with neurological deficits recovered totally or partially. X-ray or CT films showed spinal fusion in 57 patients.

Conclusion: The therapeutic effect of individuall operative options is good in treating drug-resistant spinal tuberculosis after antituberculous chemotherapy based on conventional and genotypic drug susceptibility testing.
KEYWORDS:Tuberculosis,spinal  Surgical procedures,operative  Tuberculosis,multidrug-resistant
 
引用本文,请按以下格式著录参考文献:
中文格式:李大伟,马远征,侯英,薛海滨,黄凤山.耐药脊柱结核的外科治疗[J].中国骨伤,2010,23(7):485~487
英文格式:LI Da-wei,MA Yuan-zheng,HOU Ying,XUE Hai-bin,HUANG Feng-shan.Surgical treatment of drug-resistant spinal tuberculosis[J].zhongguo gu shang / China J Orthop Trauma ,2010,23(7):485~487
View Full Text  View/Add Comment  Download reader
Close




版权所有:Editorial Office of China Journal of Orthopaedics and Traumatology京ICP备12048066号  版权声明
地址:No.16A, Nanxiaojie, Dongzhimennei, Beijing 100700, China
电话:0086-10-84036581 传真:0086-10-84036581 Email:zggszz@sina.com